Mw5152915 was received on (b)(6) 2024, reporting that the patient had an afx2 bifurcated stent graft implanted and on (b)(6) 2024 it was discovered that there was an indeterminate endoleak.Reportedly, the patient is being referred to a surgeon to have the afx2 bifurcated stent graft repaired.
|
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.Endologix could not perform an evaluation of the device as the device remains implanted in the patient.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the indeterminate endoleak complaint is unconfirmed.This is not consistent with the reported adverse event/incident.Device, user, procedure or anatomy relatedness of this complaint could not be determined.No procedure related harms for this complaint are identified.No contributing factors were identified.The final patient status is reported as stable pending surgical consultation.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.Corrections: awareness date ¿ updated investigation finding codes - remove code 3233.Investigation conclusion codes - remove code 11.
|